ProGuard Hair Loss Therapy - Toronto

What Is Proguard?

Proguard is a highly developed patented formulation of nutraceutically derived agents. It was developed with the knowledge that anti-androgenic substances, with other synergistic elements have additive effects in combating Androgenic Alopecia also known as Male / Female Pattern Hair Loss.

Established by verified peer scientific research, the individual components comprising the Proguard treatment have been created only after meticulous research into a large number of agents purported to offer benefit in the battle against Male / Female Pattern Hair Loss. After discarding most of what was examined, a short list of distinguishing agents were combined to create Proguard.

Extensive Research has gone into the development of the fundamental understanding of the substances you will find in Proguard. The individual components comprising the patented formulation are as follows: SAW PALMETTO EXTRACT, PYGEUM AFRICANUM EXTRACT, URTICA DIOICA, GREEN TEA EXTRACT, ZINC and VITAMIN B6. Furthermore, clinical trial data and peer reviewed scientific journal abstracts devoted to each ingredient is included to lend further established medical reasoning behind our decision to incorporate the ingredients into Proguard’s formula.

How Does Proguard Work?

It is understood that men and women with male / female pattern hair loss have increased levels of Dihydrotestosterone (DHT) in the scalp. DHT contributes to a shortening of the growth phase and a thinning of the hair. Proguard lowers the levels of DHT in the scalp and serum by blocking 5 alpha-reductase, an important enzyme involved in regulating the hair follicle. Proguard contributes to the normalization of the hair growth cycle and the reversal of the hair loss process naturally and without the use of prescription drugs.

Is Gender A Factor In The Use Of Proguard?

Men and Women with pattern hair loss can benefit from the use of Proguard.

How Should I Take Proguard?

Two tablets daily, with or without food or as directed by a physician.

What Kind Of Results Should I Expect?

Since normal hair usually grows 1/2 inch to 1 inch per month, treatment with Proguard takes time. Continued use for at least 3 months is usually needed before you notice any change.

Are The Any Side Effects?

The active ingredients in Proguard are derived from naturally occurring substances, with no evidence of side effects or drug interactions.

Can I Take Proguard With Other Medicines?

Proguard should not interfere with other medicines.

What Happens If I Stop Using Proguard?

Continued use of Proguard is essential to obtain maximum benefit. If you stop using Proguard, you will likely lose any of the hair you have gained or maintained by Proguard within 12 months of stopping treatment.

What Should I Do If I Miss A Dose?

If you miss a dose, do not take an extra one. Just take the next tablet as usual.

Does Proguard Effect The Hair On The Other Parts Of Your Body?

Proguard does not effect hair on other parts of the body.

When To Begin Treatment

The chart on this page is called the Norword-Hamilton rating scale. If you fit any of these classifications you are a candidate for treatment.

Established Peer Scientific References

Gormley GJ. – Biomed Pharmacother. 1195;49(7-8):319-24.
Dallob Al, et al. – J Clin Endocrinol Metab. 1994 Sep;79(3):703.
Sudduth SL et al. – Pharmacotherapy. 1993 Jul-Aug;13(4):309.
Puerto Am et al. – Rev Esp Fisiol. 1990 Sep;46(3):289-96.
Caballero MJ, et al. – Rev Esp Fisiol. 1990 Sep;46(3):283-8.
Sawaya ME et al. -J Invest Dermta. 1989 Jan;92(1):91-5.
Moltz L. – Geburtshilfe Frauenheilkd. 1988 Apr;48(4):203-14.
Caballero MJ, et al. – Rev Esp Fisiol. 1987 Jun;43(2):229-37
Wilt TJ, et al. -Jama. 1998 Nov 11;280(18):1604-9
Miller LG. – Arch Inter Med. 1998 Nov 9; 158(20):2200-11
Gerber GS. Et al. -Urology. 1998 Jun;51(6):1300-7
Harv Health Lett. 1998 May;23(7):6
Van Berkel GJ, et al. -Anal Chem. 1998 Apr 15;70(8):1544-44
Powers JE. – S D J Med. 1997 Dec;50(12):453-4
Shimada H et al. -J Nat Prod. 1997 Apr;60(4):417-8
Bracher F. Urologe A. 1997 Jan;36(1):10-7. Review
Dreikon K. et al -Urologe A. 1995 Mar;34(2):119-29 Review
Day JF et al -J Med Entomol. 1991 Jan;28(1):19-23
Breza J, et al. -Curr Med Res Opin. 1998;14(3):127-39
Yablonsky F et al. -J Urol. 1997 Jun;157(6):2381-7
Levin Rm, et al. -Eur Urol. 1997;32 Suppl 1:15-21
Dagues F et al. -Rev Prat. 1995 Feb 1;45(3):337-41. Review
Mathe G et al. -Biomed Pharmacother. 1995;49(7-8):341-3
Mathe G et al. -Biomed Pharmacother. 1995;49(7-8):339-40
Paubert-Braquet M et al. -J Lipid Mediat Cell Signal. 1994
Krzeski T et al. -Clin Ther. 1993 Nov-Dec;15(6):1011-20
Carini C et al. -Arch Ital Urol Nefrol Androl. 1991 Sep;63(3)
Barlet A et al. -Wien Klin Wochenschr. 1990 Nov23;102(22)
Menchini-Fabris GF et al. -Arch Ital Urol Nefrol Androl. 1998
Bassi P, et al. -Minerva Urol Nefrol. 1987 Jan-Mar;39(1):45-50
Clavert A, et al. -Ann Urol (Paris) 1986;20(5):341-3 French
Dufour B et al -Ann Urol (Paris). 1984 May 18(3):193-5 French
Longo R et al. -Farmaco (Prat) 1983 Jul;38(7):287-92
Pierini N, et al. -Boll Chim Farm. 1982 Jan;121(1):27-34.
Casella G. et al. -Arch Sci Med (Torino). 1978 Jan-Mar;135(1)
Thiebolt L. et al. -Therapie. 1977 Jan-Feb;32(1):99110.
Thieblot L. et al. – Therapie. 1971 May-Jun;26(3):575-80.
Dubois B, et al. -FEBS Lett. 1998 May 8;427(2):275-8
Schottner M et al. -Planta Med 1997 Dec;63(6):529-32
Ziyyat A, et al. -J Ethnopharmacol. 1997 Sep;58(1):45-54
Lichius JJ, et al. – Planta Med 1997 Aug;63(4):307-10
Siebert HC, et al. – Glycocnj J. 1997 Jun;14(4):531-4
Sibert HC, et al. -Proteins. 1997 Jun;28(2):268-84
Vahlensieck W Jr. et al. -Fortschr Med 1996 Nov 10;114
Teucher T. et al. -Arzneimittelforschung. 1996 Sep;46(9):906-10
Musette P. et al. – Eur J Immunol. 1996 Aug 26(8):1707-11
Obertreis B, et al. -Arzneimittelforschung. 1996 Apr;46(4):
Delcourt M et al. Cell Immunol 1996 Mar 15;168(2):158-64
Musett P, et al. – Eur J Immunol 1196 Mar;26(3):618-22
Basaran AA et al. -Teratog Carcinog Mutagen 1996;16(2):125
Obertreis B. et al. -Arzneimittelforschung 1996 Jan;46(1):52-6
Zanglis A et al. -Int J Biochem Cell Biol. 1996 Jan;28(1):63-74
Davidov MI et al. -Urol Nefrol (mosk). 1995 Sep-Oct(5):19-20
Kayser K et al. – Anal Quant Cytol Histol. 1995 Apr;17(2):135
Hom K et al. -Febs Lett 1995 Mar 20;361(2-3):157-61
Galelli A et al. -J Immunol 1995 Mar 15;154(6):2600-11
Hyrb DJ et al. -Planta Med. 1995 Feb;61(1):31-2
Hirano T. et al. -Plant Med. 1994 Feb;60(1):30-3
Krzeski T. et al. -Clin Ther. 1993 Nov-Dec;15(6):-20
Iseli B et al. -Plant Physiol. 1993 Sep;103(1):221-6
Galelli et al J Immunol 1993 Aug 15;151(4):1821-31
Pusztai A et al. -Br J Nutr. 1993 Jul;70(1):313-21
Lerner Dr. et al. – J Biol Chem. 1992 Nov 5;267(31):22694
Le Moal Ma et al. -Res Immunol 1992 Sep;143(7):701-9
Le Moal et al. -Res Immunol. 1992 Sep;143(7):691-700
Lerner Dr et al. -J biol Chem 1992 Jun 5;267(16):11085-91
Balzarini J et al. -Antiviral Res. 1992 Jun;18(2):191-207
Beintema JJ, et al. -Febs Lett. 1992 Mar 9;299(2):131-4
Roman Ramos R et al. -Arch Med Res. 1992 Spring;23(1):59
De Bolle MF et al. -Electrophoresis. 1991 Jun;12(6):442-4
Oliver F et al. -Clin Exp Dermatol. 1991 Jan;16(1)1-7
Mittman P. -Planta Med 1990 Feb;56(1):44-7
Wagner H et al. -Planta Med 1989 Oct;55(5):452-4 German
Krivenko VV et al. – Vrach Delo 1989 Mar;(3)76-8 Russian
Swanston-Flatt Sk et al. -Diabetes Res. 1989 Feb;10(2):69-73
Le Moal Ma et al. -Cell Immunol. 1998 Aug;115(1):24-35
Wieringa Pa et al -Am J Physiol 1988 Apr;254(4 pt 2):h636-50
Shibuya N et al. -Arch Biochem Biophys 1986 Aug 15;249
Traas Ja et al. -J Cell Sci. 1985 Jun;76:303-20
Smallman Bn et al. -Biochem J.1981 Jan 15;194(1):361-4
Piekos R et al. -Plant Med. 1976 Dec;30(4):331-6
Radunz A. – Z Naturforsch {c} 1976 Sep-Oct;31(9-10):589-93
Oxford GS. -Heredity (Edinburgh) 1975 Dec;35(3):361-70
Shiina H et al. – Prostate.1996 Sep;29(3):169-76
Shiina H et al. – Br J Urol 1996 Jan;77(1):96-101
Fahim MS et al -Andrologia. 1993 Nov-Dec;25(6):369-75
Habib FK et al. – Urol Res. 1992;20(4):281-4
Hudson RW. – J Steroid Biochem . 1987 Mar;26(3):349-53
Suesum MO, et al. -J Androl. 1985 Jan-Feb;6(1)10-4
Lahtonen R. -Prostate. 1985;6(2):177-83
Singuim G et al. -J Steroid Biochem. 1984 Mar;20(3):773-80
Bermudez JA et al. – Arch Androl. 1982 Sep;9(2):167-9
Exaire E et al. -Arch Androl. 1982 Sep;9(2):183-7
Paniagua R et al.-Arch Androl. 1982 Jun;8(4):271-5
Terracio L et al. -Prostate. 1982;3(2):183-91
Netter A. et al. Arch Androl. 1981 Aug;7(1):69-73
Habib FK et al. –J Endrocrinol. 1976 Oct;71(1):133-41

ProGuard Hair Loss Therapy – Toronto